Liangxue-Qushi-Zhiyang Decoction Ameliorates DNCB-Induced Atopic Dermatitis in Mice through the MAPK Signaling Pathway Based on Network Pharmacology
Main Authors: | Lili Zhang, Huili Zhang, Xiaoyu Niu, Xuan Zhang, Xingtong Chen, Shengyi Lei, Shengnan Ma, Zhanxue Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-04-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c09218 |
Similar Items
-
Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
by: Yanjie Wang, et al.
Published: (2022-12-01) -
Therapeutic effects of the Qingre-Qushi recipe on atopic dermatitis through the regulation of gut microbiota and skin inflammation
by: Fang Shen, et al.
Published: (2024-02-01) -
Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model
by: Rebecca Riedl, et al.
Published: (2023-08-01) -
Paedoksan ameliorates allergic disease through inhibition of the phosphorylation of STAT6 in DNCB-induced atopic dermatitis like mice
by: Sang Heon Lee, et al.
Published: (2023-09-01) -
Anti-Inflammatory Effects of M-MSCs in DNCB-Induced Atopic Dermatitis Mice
by: Bokyeong Ryu, et al.
Published: (2020-10-01)